logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9751825 B1

PDFFull Text
Expired
Date of Patent:
Sep. 05, 2017

Filed:

Jul. 19, 2012

Tak1 kinase inhibitors, compositions, and used related thereto

Applicants:

Huw M. L. Davies, Duluth, GA (US);

Spandan Chennamadhavuni, Natick, MA (US);

Andrei Bakin, Buffalo, NY (US);

Inventors:

Huw M. L. Davies, Duluth, GA (US);

Spandan Chennamadhavuni, Natick, MA (US);

Andrei Bakin, Buffalo, NY (US);

Assignee:

Emory University, Atlanta, GA (US);

Attorney:

Emory Patent Group

Primary Examiner:

Samantha Shterengarts

Int. Cl.
CPC ...
A61K 31/194 (2006.01); A61K 31/216 (2006.01); A61K 31/343 (2006.01); A61K 31/357 (2006.01); A61K 31/36 (2006.01); A61K 31/405 (2006.01); C07C 69/73 (2006.01); C07C 69/604 (2006.01); C07C 69/618 (2006.01); C07C 69/65 (2006.01); C07C 69/732 (2006.01); C07C 69/734 (2006.01); C07C 69/738 (2006.01); C07D 317/60 (2006.01); C07D 319/18 (2006.01); C07D 209/26 (2006.01); C07D 209/34 (2006.01); C07D 307/79 (2006.01); C07C 259/06 (2006.01); C07C 205/56 (2006.01); C07C 51/00 (2006.01); C07C 57/42 (2006.01); C07C 67/31 (2006.01); C07C 69/736 (2006.01); C07C 201/12 (2006.01); C07D 209/24 (2006.01); C07D 307/80 (2006.01); C07D 317/68 (2006.01);
U.S. Cl.
CPC ...
C07C 69/73 (2013.01); A61K 31/194 (2013.01); A61K 31/216 (2013.01); A61K 31/343 (2013.01); A61K 31/357 (2013.01); A61K 31/36 (2013.01); A61K 31/405 (2013.01); C07C 51/00 (2013.01); C07C 57/42 (2013.01); C07C 67/31 (2013.01); C07C 69/604 (2013.01); C07C 69/618 (2013.01); C07C 69/65 (2013.01); C07C 69/732 (2013.01); C07C 69/734 (2013.01); C07C 69/736 (2013.01); C07C 69/738 (2013.01); C07C 201/12 (2013.01); C07C 205/56 (2013.01); C07C 259/06 (2013.01); C07D 209/24 (2013.01); C07D 209/26 (2013.01); C07D 209/34 (2013.01); C07D 307/79 (2013.01); C07D 307/80 (2013.01); C07D 317/60 (2013.01); C07D 317/68 (2013.01); C07D 319/18 (2013.01);
Abstract

The disclosure relates to TAK1 inhibitors, compositions, and uses related thereto. In certain embodiments, the disclosure relates to compounds of formula (I), pharmaceutical compositions having a compound of formula (I), and methods of treating or preventing cancer by administering an effective amount of a pharmaceutical composition having a compound of formula (I) to a subject in need thereof.

Find Patent Forward Citations

Davies, Huw M. L.. (2017). Tak1 kinase inhibitors, compositions, and used related thereto (U.S. Patent No. 9751825). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9751825

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…